Mercor’s Brendan Foody Blasts Sequoia Over Dual‑Pricing Valuation Tactics
Brendan Foody, co‑founder of the AI talent platform Mercor (last valued at $10 billion), used X to denounce Sequoia Capital for allegedly structuring investments in two tranches at vastly different valuations, a practice he termed the “Sequoia scam.” The allegation adds to a wave of founder complaints about opaque VC tactics.
Foody’s Public Accusation of Sequoia’s Dual‑Pricing Scheme
Foody wrote that in the past six months he observed “a half dozen rounds where Sequoia invests in 2 tranches. Everyone pretends they only did the higher valuation.” He argues that founders misrepresent the lower‑priced tranche to employees and angels, creating a misleading perception of market dominance.
Valuation Gaps Highlighted by Recent Funding Rounds
- AI‑driven helpdesk startup Serval announced a $75 million Series B at a $1 billion headline valuation, but Sequoia’s lowest entry point was reported at $400 million (Wall Street Journal).
- Market‑research AI startup Aaru disclosed a $1 billion headline price while lead investor Redpoint backed it at a $450 million valuation.
- These examples illustrate a “blended” price that is often far lower than the public figure used for PR and talent recruitment.
Implications for Startup Transparency and Employee Compensation
Jason Woo, partner at Armanino, notes that employee stock options should be priced based on the blended valuation, but 409A appraisals—used to set strike prices—are traditionally low, creating a structural incentive to keep option costs down. Consequently, employees may benefit from lower tax bills but remain unaware of the true market perception.
Angels, unlike employees, receive no independent appraisal, leaving them reliant on the numbers founders choose to disclose.
Future Outlook for VC Valuation Practices
Sequoia’s Shaun Maguire defended the two‑tranche approach as a market reality, claiming it reflects a “repeated game” where VCs avoid overpaying for hot deals. However, the practice raises questions about ethical standards and could prompt tighter disclosure norms if founder backlash intensifies.
Industry observers suggest that continued scrutiny may lead to more standardized reporting of tranche‑level pricing, greater alignment of 409A valuations with headline numbers, and heightened vigilance from founders and employees alike.